Rispenzepine is an atypical antipsychotic medication primarily used in the field of psychiatry for treating schizophrenia and bipolar disorder. It exerts its effects by antagonizing dopamine D2 and serotonin 5-HT2A receptors in the brain, which helps reduce symptoms such as delusions, hallucinations, disorganized thinking, and mood instability. This compound is also indicated for managing irritability associated with autistic disorder in children and adolescents, as well as other conditions involving psychotic features. Ongoing research explores its role in treating anxiety and depressive symptoms in psychiatric contexts. Due to potential side effects like extrapyramidal symptoms and metabolic changes, it requires prescription by specialized physicians and close clinical monitoring.